ARTICLE | Company News
Corixa, GSK submit Bexxar response
September 7, 2001 7:00 AM UTC
CRXA and partner GlaxoSmithKline (GSK; LSE:GSK) submitted final responses to the FDA's complete review letter regarding their BLA for Bexxar tositumomab radiolabeled anti- CD20 monoclonal antibody. Ea...